share_log

业聚医疗(06929):建议撤销现有一般授权并授予新一般授权

Orbusneich (06929): It is recommended to revoke the existing general authorization and grant a new general authorization.

Zhitong Finance ·  Nov 15 16:38

According to the latest revision of the listing rules, Orbusneich (06929) announced that starting from June 2024...

According to the announcement from Orbusneich (06929) on the Smart Finance app, in view of the latest revision on the rules related to treasury shares, effective from June 11, 2024, the board of directors proposes to revoke the general authorization granted to directors at the annual general meeting of shareholders held on June 6, 2024, and seek shareholders' approval at the upcoming special general meeting of shareholders to grant new general authorization to the directors. At the special general meeting of shareholders, a resolution will be presented for consideration by shareholders to revoke the existing general authorization and to grant new general authorization to the directors. The board of directors believes that revoking the existing general authorization and granting new general authorization will provide the company with flexibility to repurchase shares and hold the repurchased shares as treasury shares for further issuance, sale, and/or transfer (including granting any share purchase rights or share incentives under any share schemes of the company).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment